KindlyMD (NASDAQ:NAKA) Shares Gap Up - Should You Buy?

Key Points

• KindlyMD's share price increased from $1.24 to $1.35 at the market opening, with the latest trading price at $1.41 and a significant volume of 17.7 million shares traded.
• Maxim Group has initiated coverage on KindlyMD with a "buy" rating and set a price target of $8.00, which aligns with the average rating of "Buy" from analysts.
• The company recently reported a negative earnings per share of ($0.34) and had a market capitalization of $567.94 million.

KindlyMD, Inc. (NASDAQ:NAKA - Get Free Report) shares gapped up prior to trading on Tuesday . The stock had previously closed at $1.24, but opened at $1.35. KindlyMD shares last traded at $1.41, with a volume of 17,742,906 shares.

Analyst Ratings Changes

Separately, Maxim Group began coverage on shares of KindlyMD in a report on Wednesday, September 3rd. They issued a "buy" rating and a $8.00 price objective for the company. One investment analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus target price of $8.00.

KindlyMD Trading Down 6.0%

The firm's fifty day moving average price is $8.04.

KindlyMD (NASDAQ:NAKA - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported ($0.34) earnings per share for the quarter. KindlyMD had a negative net margin of 244.00% and a negative return on equity of 131.09%. The firm had revenue of $0.41 million for the quarter.

KindlyMD Company Profile

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population.